MCD
52
5
VLO
20
-9
T
51
-2
USB
46
-5
HAL
30
-9
PNW
52
-3
ESS
27
-6
ADBE
40
-4
EMC
14
-12
ZTS
6
-10
WMB
44
-4
UNP
32
-4
DHI
28
-4
VRTX
44
-4
GOOGL
34
-9
SPG
32
-8
HD
37
-4
CA
7
-3
REGN
23
-6
EMR
33
-7
MCD
52
5
VLO
20
-9
T
51
-2
USB
46
-5
HAL
30
-9
PNW
52
-3
ESS
27
-6
ADBE
40
-4
EMC
14
-12
ZTS
6
-10
WMB
44
-4
UNP
32
-4
DHI
28
-4
VRTX
44
-4
GOOGL
34
-9
SPG
32
-8
HD
37
-4
CA
7
-3
REGN
23
-6
EMR
33
-7
Financhill
Back

Creative Realities Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
17

CREX
Creative Realities

Last Price:
$1.41
Seasonality Move:
11.49%
Sell
48

SRPT
Sarepta Therapeutics

Last Price:
$50.83
Seasonality Move:
12.51%
Sell
17
Creative Realities (CREX) is a Sell

Is Creative Realities a Buy, Sell or Hold?

  • The current Creative Realities [CREX] share price is $1.45. The Score for CREX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • CREX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $50.31. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CREX Stock Price Chart

What is Creative Realities's stock price today?

  • The Creative Realities share price today is $1.45
    The current trend is relatively stagnant and CREX is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $50.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

CREX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 28.13 Sell
Chaikin Money Flow: -37259 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.69 - 2.03) Sell
Bollinger Bands (100): (1.99 - 3.07) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -12.43 Sell
Relative Strength Index (14 RSI): 25.41 Sell
Chaikin Money Flow: -2337291 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.24 - 93.24) Sell
Bollinger Bands (100): (85.21 - 128.11) Sell

CREX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.71 Sell
20-day SMA: 1.87 Sell
50-day SMA: 2.13 Sell
200-day SMA: 3.5 Sell
8-day EMA: 1.62 Sell
20-day EMA: 1.41 Buy
50-day EMA: 0.86 Buy
200-day EMA: 0.27 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.64 Sell
20-day SMA: 68.68 Sell
50-day SMA: 92.51 Sell
200-day SMA: 121.01 Sell
8-day EMA: 56.28 Sell
20-day EMA: 67.87 Sell
50-day EMA: 86.24 Sell
200-day EMA: 111.03 Sell

Creative Realities Earnings Growth & CREX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.35 per share, a decrease next quarter of $0.47 per share, an increase this year of $4.58 per share, and an increase next year of $5.49 per share.

Creative Realities Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):